Two of seven tetracycline-resistant (Tcr) Mycobacterium fortuitum group isolates and six Tcr clinical Streptomyces isolates carried gram-positive Tcr determinants (Tet K and Tet L) and Streptomyces resistance determinants (Otr A, Otr B, and Otr C). This represents the first documentation of the aquisition by mycobacteria of determinants coding for antibiotic resistance and suggests the potential for the spread of antibiotic resistance determinants within mycobacterial species.
The nontuberculous mycobacteria and Streptomyces spp. are commonly found in soil. Many species in these groups, including Mycobacterium marinum, the pathogenic, rapidly growing mycobacteria (Mycobacterium fortuitum and Mycobacterium chelonae), and various Streptomyces spp., are capable of causing skin and skin-related infections following penetrating trauma (28) . Prior to the 1970s, the potential of the tetracyclines (including doxycycline and minocycline) for use in the therapy of infections caused by these organisms was unknown. In 1981 , Dalovisio et al. (5) reported successful treatment outcomes of skin and soft tissue infections caused by M. fortuitum in three patients treated with doxycycline alone and of an infection caused by M. abscessus (formerly M. chelonae subsp. abscessus) in one patient treated with doxycycline in combination with amikacin. Since then, there have been numerous reports of favorable treatment outcomes that were obtained when tetracyclines were used to treat soft tissue or bone infections caused by rapidly growing mycobacteria (21) .
The in vitro tetracycline susceptibilities among the groups of pathogenic, rapidly growing mycobacteria are highly variable.
Approximately 100% of the Mycobacterium smegmatis and 50% of the M. fortuitum (formerly M. fortuitum biovariant fortuitum) isolates are susceptible to doxycycline (MICs c4 jig/ml), whereas fewer than 25% of the M. fortuitum third biovariant complex, M. abscessus (formerly M. chelonae subsp. abscessus), and M. chelonae (formerly M. chelonae subsp. chelonae) are susceptible to doxycycline (24) (25) (26) (27) .
Recent increases in the number of cases of tuberculosis and diseases caused by the nontuberculous mycobacteria have been described (4, 8, 24, 25, 28) . A limited number of active antimycobacterial agents are available, and little is known about the biochemical mechanisms and genetics of antimicrobial resistance in mycobacterial species, including resistance to tetracyclines.
Plasmids have been recognized in most species of nontuberculous mycobacteria, but they are not known to carry antibiotic resistance determinants (9, (11) (12) (13) 23) . Antibiotic resistance toward isoniazid and rifampin in Mycobacterium tuberculosis has been linked to chromosomal mutations or deletions of existing genes (10, 22, 29) (15, 20) . Because (6, 7) , while the mechanism for Otr C is unknown. Hybridization with radiolabelled DNA was done under stringent conditions of 42°C with 50% (vol/vol) formamide, 0.1% (wt/vol) polyvinylpyrrolidone, 0.1% (wt/vol) albumin, 0.1% (wt/vol) Ficoll, 0.1% (wt/vol) sodium dodecyl sulfate (SDS), 0.05 M monobasic sodium phosphate (pH 7.4), 0.005 M EDTA, 0.76 M NaCl, and 200 ,ug of boiled calf thymus DNA per ml overnight (16, 17) . The filters were then washed three times for 10 min each time at 52°C in 0.1% SDS-0.015 M NaCl-0.0015 M sodium citrate; this was followed by three 10-min washes at 52°C in 0.015 M NaCl-0.0015 M sodium citrate. These conditions required >80% sequence identity between the template and labelled DNA for a positive hybridization reaction (16 Fig. 1 ). The PCR product from the M. fortuitum third biovariant complex ATCC 49403 was extracted by using an extraction kit (Qiagen, Chatsworth, Calif.) and was sequenced with a sequencing kit (Applied Biosystems, Foster City, Calif.) on model 373A sequencer (Applied Biosystems). The Tet K primers amplified a sequence spanning nucleotides 1110 to 2140 of tetK from pT181 (GenBank accession number J01764). The first 300 bp of the PCR-generated sequence was matched between nucleotides 1820 and 2120 of the Tet K determinant from pT181 and had 98% identity (Fig. 2) . A similar degree of identity was seen with the Tet K determinant from plasmid pNS1 (GenBank accession number M16217) (data not shown). As with all other tetK and tetL sequences, the sequence from M. fortuitum had a G+C content of approximately 35%, which is significantly different from the approximate 70% G+C content found in streptomyces and mycobacteria (14, 15, 19) . Previously, we have found the Tet L determinant in members of the genera Actinomyces, Clostridium, Enterococcus, Listeria, Peptostreptococcus, and Streptococcus (15, 16) , while other investigators have found Tet L in members of the genera Bacillus, Enterococcus, Staphylococcus, and Streptococcus (20) . Similarly, the Tet K determinant is associated with members of the genera Bacillus, Clostridium, Enterococcus, Eubacterium, Listeria, Peptostreptococcus, Staphylococcus, and Streptococcus (15, 16, 20) . However, this report represents the first time that either of these determinants has been described in members of the genera Mycobacterium and Streptomyces. Because the Tet K and Tet L determinants have a low G+C content, can be transferred by conjugation to other species, and are found in a number of gram-positive species (15, 16, 20) (16) .
Most bacteria become clinically resistant to antibiotics by acquiring new determinants which are then capable of moving to other isolates and species (15) . The transfer frequencies of these determinants are usually greater when both the donor and the recipient are of the same or related species (15) . Streptomyces spp. are gram-positive bacteria with traits related to those found in the genus Mycobacterium, and members of the two genera share the same habitat (14, 19 The data presented here suggest the potential for the spread of an antibiotic resistance gene into all environmental (nontuberculous) mycobacteria, including Mycobacterium leprae. Therefore, monitoring of mycobacteria for the development of Tcr should be considered. In addition, rRNA methylase determinants, which confer resistance to lincosamides and the new macrolides, are often associated with the Tet determinants (3, (1) (2) (3) (4) (5) . Use of the new macrolides in the treatment and, possibly, the prophylaxis of disseminated Mycobacterium avium complex infections in patients with AIDS and patients with disease caused by rapidly growing mycobacterial (24, 27) could provide the pressure to introduce one of these mobile methylase determinants as well as enhance the spread of the Tet determinants into mycobacterial species.
